Evidence map›Paper›PMID 39992505›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Assays of Different Mechanisms of AMPK Activation, and Use of Cells Expressing Mutant AMPK to Delineate Activation Mechanisms.

Fiona A Ross, D Grahame Hardie

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fiona A RossDivision of Cell Signalling & Immunology, School of Life Sciences, University of Dundee, Dundee, UK.
D Grahame HardieDivision of Cell Signalling & Immunology, School of Life Sciences, University of Dundee, Dundee, UK. d.g.hardie@dundee.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotic cells not only sense carbon nutrients directly, but also sense them indirectly by monitoring the levels of cellular adenine nucleotides produced by their catabolism. Starvation for a key carbon source may cause increases in ADP:ATP ratios that are amplified by the adenylate kinase reaction (2ADP ↔ ATP + AMP) into even larger increases in AMP:ATP ratios. The major cellular sensor of such changes in nucleotide levels is the AMP-activated protein kinase (AMPK) which, once activated, acts to restore energy balance within cells. Increases in the AMP:ATP ratio result in conformational changes in AMPK that: (1) cause allosteric activation; (2) promote phosphorylation at a critical threonine residue (Thr172) in the kinase domain of AMPK-α subunits by the upstream kinase LKB1; (3) protect against Thr172 dephosphorylation by protein phosphatases. Together, these three mechanisms of activation can cause up to a 1000-fold increase in AMPK activity, and this chapter will describe assays to monitor these different activation mechanisms in cell-free assays. Adenine nucleotides (AMP/ADP/ATP) bind to sites formed by sequence repeats termed CBS motifs in the AMPK-γ subunits. Several pathogenic mutations in these motifs have been identified that either reduce or eliminate the sensitivity of AMPK to changes in AMP and other nucleotides. We also describe the use of cells expressing such mutants to determine whether agents that activate AMPK do so by disturbing adenine nucleotide levels.

Indexed as

AMP-Activated Protein KinasesEnzyme AssaysMutationAdenosine MonophosphateAdenosine TriphosphateAnimalsEnzyme ActivationHumansPhosphorylationAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesAMP-activated protein kinaseAMP-insensitive mutantsAMPKDephosphorylationKinase assaysPhosphorylation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.